로딩 중…
지수 로딩 중…
GSK plc
GSK· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
GB
GB$50.66-2.86%
2026-06-18
Price Chart
GSK plc+31.11%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $101.66B |
| Revenue | $43.30B |
| Net Income | $7.70B |
| Total Assets | $111.55B |
| Net Assets | $31.68B |
| Value | |
| P/E | 13.20x |
| P/B | 3.21x |
| PEG | 1.90x |
| P/S | 2.35x |
| EV/EBITDA | 8.69x |
| FCF Yield | 8.10% |
| Profitability | |
| ROE | 24.31% |
| ROA | 6.90% |
| Op. Margin | 25.67% |
| Revenue Growth | 1.50% |
| Earnings Growth | 6.96% |
| Financial Health | |
| Debt Ratio | 254.58% |
| Total Debt | $33.81B |
| FCF | $8.24B |
| Cash | $6.11B |
| Current Ratio | 0.79x |
| Net Debt/EBITDA | 1.86x |
| Dividend | |
| Div. Yield | 3.68% |
| Div. Growth | 2.61% |
| Performance | |
| 1Y Return | 31.11% |
| 1M Return | -0.76% |
| From 52W High | -17.89% |
| 1Y MDD | -19.91% |
| Trading | |
| Volume | 3,687,723 shares |
| Trading Value | $188M |
| Per Share | |
| EPS | $3.68 |
| BPS | $10.51 |